Gelteq Limited Ordinary Shares Stock (NASDAQ:GELS)
Previous Close
$1.05
52W Range
$0.67 - $4.11
50D Avg
$0.98
200D Avg
$1.40
Market Cap
$9.04M
Avg Vol (3M)
$2.04M
Beta
-0.62
Div Yield
-
GELS Company Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.